GBE Deficiency (GSD IV and APBD) Natural History Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Progression of disease
研究概览
简要总结
Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or Adult Polyglucosan Body Disease (APBD generated during clinic visits.
详细描述
This natural history study will serve as a repository of clinical, laboratory, and biochemical information on individuals with GBE deficiency, diagnosed as either GSD IV or APBD. This information will allow a more definitive description of GBE deficiency to be developed, which will permit development of treatment strategies for this disease.
Duke will be the only site where this study takes place. However, since this is a rare disorder, participants who receive care for GBE deficiency at other institutions will be included. We will collect retrospective data from patient charts on diagnosed individuals, as far back as necessary to capture the clinical course of the disorder. Prospective data collected from patient charts after enrollment will be captured as well. Participant's medical records will be continually reviewed for the duration of the study.
Data will be collected from medical records and will only pertain to clinically relevant information, including, but not limited to: demographic and diagnostic information, tissue biopsy results, medical and family history, review of systems, imaging studies, results of liver, muscle, and nerve function testing, and urine and blood laboratory results.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 0 Years 至 90 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of GSD IV or APBD via:
- •Two variants in the GBE1 gene
- •Deficient GBE activity in liver, muscle, skin fibroblast or other tissue
- •One variant in GBE1 gene with evidence of disease that is pathogenic, per the clinician
- •Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative)
- •Able to provide consent for release of medical records
- •Pregnant women with a diagnosis of GSD IV or APBD will be included
- •Histology as confirmed by clinician
排除标准
- 未提供
结局指标
主要结局
Progression of disease
时间窗: Duration of study, approximately 10 years
次要结局
未报告次要终点
